Log in to search using one of your social media accounts:


Ranitidine Tablets (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - September 8, 2017 Category: Drugs & Pharmacology Source Type: news

Heartburn drugs linked to premature death
Conclusion This larger set of observational data finds that PPI drugs are associated with an increase in the risk of early death compared with either H2 blockers or no acid suppression drugs. This was the case for participants both with and without gastrointestinal problems. It also appears as though the longer the PPIs drugs are taken, the greater the risk of death. Considering that these drugs are widely used in the UK, these findings may cause concern. But the research has a number of important limitations: The study was conducted in a population of mostly white, older US male veterans, which might limit the abi...
Source: NHS News Feed - July 4, 2017 Category: Consumer Health News Tags: Medication Source Type: news

Zantac Injection (Ranitidine Hydrochloride Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 8, 2017 Category: Drugs & Pharmacology Source Type: news

Ranitidine Injection, USP (Updated - Currently in Shortage)
Updated Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - January 6, 2017 Category: Drugs & Pharmacology Source Type: news

This Popular Kind Of Heartburn Medicine Can Increase Stroke Risk
This study further questions the cardiovascular safety of these drugs,” Sehested said. Although the study found an association between PPIs and stroke risk, it does not prove cause and effect. More studies are needed, and doctors should consider if and for how long patients should take these drugs, the researchers said. [7 Bizarre Drug Side Effects] PPIs are not the only medicines available to treat heartburn. The researchers noted that another type of heartburn medication, called a histamine H2 antagonist, was found to have no association with stroke risk in the study. Histamine H2 antagonists include famotidine (Pe...
Source: Science - The Huffington Post - November 21, 2016 Category: Science Source Type: news

Test your readiness with this month ’s USMLE Step 1 stumper
The United States Medical Licensing Examination ® (USMLE®) Step 1 exam is often the first major test of a medical student’s knowledge, and some of its questions are missed by all but a select few highly prepared test takers. Check out this month’s question that Kaplan Medical says stumps most students, and view an expert video explanation o f the answer. Welcome to this month ’s installment of the AMA Wire® series, Tutor talk: Tips from Kaplan Medical on the most missed USMLE test prep questions from Kaplan’s Qbank: Step 1. Each month,AMA Wire ®reveals questions many physicians...
Source: AMA Wire - September 26, 2016 Category: Journals (General) Authors: Timothy Smith Source Type: news

Zantac (Ranitidine Hcl) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 1, 2016 Category: Drugs & Pharmacology Source Type: news

Strides Shasun gets USFDA tentative nod for Ranitidine tablets
In a BSE filing, Strides Shasun said "it has received approval from the US Food and Drug Administration (USFDA) for Ranitidine tablets USP, 150 mg and 300 mg". (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 24, 2016 Category: Pharmaceuticals Source Type: news

Taking Certain Heartburn Meds Linked To Higher Risk Of Heart Attack
By Kathryn Doyle (Reuters Health) - People who take certain popular heartburn medications, like omeprazole (Prilosec), are at increased risk of heart attack, according to a data mining study by U.S. researchers. The drugs, called proton-pump inhibitors (PPIs), lower acidity in the stomach and prevent the burning sensation in the esophagus that indicates acid reflux. There have been questions about the safety of these drugs for people who have had a coronary event like a heart attack, said lead author Nigam H. Shah of Stanford University in California, but most research has focused on the interaction be...
Source: Science - The Huffington Post - June 10, 2015 Category: Science Source Type: news

Sriracha, Zohydro, and more: tox on the web
  http://www.youtube.com/watch?v=U2DJN0gnuI8 The science of Sriracha: The American Chemical Society has a must-see video on Sriracha hot sauce — it goes well with everything — including disquisitions about the origin of the Scoville scale and the physiology of capsaicinoids. (HT @ToxTalk) Early ads for sedatives: The Milwaukee Journal-Sentinel — which is doing some of the best reporting in the country on drugs and the pharmaceutical industry — has a great collection of medical journal ads for tranquilizers from the 1950s and 60s.  This post accompanies their story...
Source: The Poison Review - March 5, 2014 Category: Toxicology Authors: Leon Tags: Medical amphetamine drug screen capsaicin did she kill him Florence Maybrick gravel Kate Coloquhoun PVP pyrrolidinopentiophenone scoville scale sedative sriracha tox on the web tranquilizer advertisement zohydro Source Type: news

Leanne Howes shed her skin after allergic reaction to HEARTBURN tablets
WARNING GRAPHIC CONTENT: Leanne Howes, from Norwich, developed Stevens-Johnson syndrome after taking Zantac Ranitidine prescribed by her doctor. (Source: the Mail online | Health)
Source: the Mail online | Health - February 20, 2014 Category: Consumer Health News Source Type: news

Prevalence of anticholinergic use among older home health patients
Source: Journal of Clinical Nursing Area: Evidence> Medicines Management> References Anticholinergic usage patterns for patients in the USA aged 65 years and older who received home health (HH) services were examined using the 2007 National Home and Hospice Care Survey (NHHCS) data. Slightly over 80% (80.30; 95% CI, 77.5 to 83.25) of older HH patients received at least one anticholinergic drug. High prevalence of the use of higher level anticholinergics was found.  Almost 30% (29.62; 95% CI, 26.90 to 32.33) took either a level 2 (5.42%; 95% CI, 4.00 to 6.85) or level 3 (25.99%; 95% CI, 23.54 to 28.44) dr...
Source: NeLM - Care of Older People - January 9, 2013 Category: Geriatrics Source Type: news